Neoventa Medical AB is a Swedish medical device company founded in 1997 by Professor KG Rosén, a renowned physiologist, pediatrician, and neonatologist trained at the University of Gothenburg. Neoventa specializes in innovative fetal monitoring solutions designed to enhance obstetric care, improve patient safety, and support clinical decision-making.

The company is known for its Stan fetal and maternal monitor, which integrates evidence-based ST analysis of the fetal ECG as an adjunct to CTG, offering healthcare professionals a "second pair of eyes" during childbirth. Neoventa also produces Goldtrace disposable fetal scalp electrodes for internal fetal monitoring and offers comprehensive training through its Neoventa Academy, including e-learning and certification programs.

Numerous clinical studies demonstrate that Neoventa's solutions help reduce the risk of neurological damage in newborns, lower operative delivery rates, and optimize cost-effectiveness. With a strong commitment to quality, the company operates under MDR 2017/745 and ISO 13485 standards. Headquartered in Gothenburg, Sweden, Neoventa's products have supported over a million births worldwide.